UPDATE 1-Roche clears UK hurdle in $4.3 bln Spark deal, U.S. review drags on
December 16, 2019 at 02:42 AM EST
Swiss drugmaker Roche won clearance from Britain's Competition and Markets Authority (CMA) on Monday for its planned $4.3 billion takeover of gene therapy company Spark Therapeutics, while a similar U.S. review continues.